TY - JOUR
T1 - Systematic Reviews and Meta-Analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery
AU - Lavikainen, Lauri I.
AU - Guyatt, Gordon H.
AU - Sallinen, Ville J.
AU - Karanicolas, Paul J.
AU - Couban, Rachel J.
AU - Singh, Tino
AU - Lee, Yung
AU - Elberkennou, Jaana
AU - Aaltonen, Riikka
AU - Ahopelto, Kaisa
AU - Beilmann-Lehtonen, Ines
AU - Blanker, Marco H.
AU - Cárdenas, Jovita L.
AU - Cartwright, Rufus
AU - Craigie, Samantha
AU - Devereaux, P. J.
AU - Garcia-Perdomo, Herney A.
AU - Ge, Fang Zhou
AU - Gomaa, Huda A.
AU - Halme, Alex L.E.
AU - Haukka, Jari
AU - Karjalainen, Päivi K.
AU - Kilpeläinen, Tuomas P.
AU - Kivelä, Antti J.
AU - Lampela, Hanna
AU - Mattila, Anne K.
AU - Najafabadi, Borna Tadayon
AU - Nykänen, Taina P.
AU - Pandanaboyana, Sanjay
AU - Pourjamal, Negar
AU - Ratnayake, Chathura B.B.
AU - Raudasoja, Aleksi
AU - Vernooij, Robin W.M.
AU - Violette, Philippe D.
AU - Wang, Yuting
AU - Xiao, Yingqi
AU - Yao, Liang
AU - Tikkinen, Kari A.O.
N1 - Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024/2/1
Y1 - 2024/2/1
N2 - Objective: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery. Background: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and bleeding risks that vary between procedures; their magnitude remains uncertain. Methods: We identified observational studies reporting procedure-specific risks of symptomatic VTE or major bleeding after abdominal surgery, adjusted the reported estimates for thromboprophylaxis and length of follow-up, and estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated evidence certainty. Results: After eligibility screening, 285 studies (8,048,635 patients) reporting on 40 general abdominal, 36 colorectal, 15 upper gastrointestinal, and 24 hepatopancreatobiliary surgery procedures proved eligible. Evidence certainty proved generally moderate or low for VTE and low or very low for bleeding requiring reintervention. The risk of VTE varied substantially among procedures: in general abdominal surgery from a median of <0.1% in laparoscopic cholecystectomy to a median of 3.7% in open small bowel resection, in colorectal from 0.3% in minimally invasive sigmoid colectomy to 10.0% in emergency open total proctocolectomy, and in upper gastrointestinal/hepatopancreatobiliary from 0.2% in laparoscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer. Conclusions: VTE thromboprophylaxis provides net benefit through VTE reduction with a small increase in bleeding in some procedures (eg, open colectomy and open pancreaticoduodenectomy), whereas the opposite is true in others (eg, laparoscopic cholecystectomy and elective groin hernia repairs). In many procedures, thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.
AB - Objective: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery. Background: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and bleeding risks that vary between procedures; their magnitude remains uncertain. Methods: We identified observational studies reporting procedure-specific risks of symptomatic VTE or major bleeding after abdominal surgery, adjusted the reported estimates for thromboprophylaxis and length of follow-up, and estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated evidence certainty. Results: After eligibility screening, 285 studies (8,048,635 patients) reporting on 40 general abdominal, 36 colorectal, 15 upper gastrointestinal, and 24 hepatopancreatobiliary surgery procedures proved eligible. Evidence certainty proved generally moderate or low for VTE and low or very low for bleeding requiring reintervention. The risk of VTE varied substantially among procedures: in general abdominal surgery from a median of <0.1% in laparoscopic cholecystectomy to a median of 3.7% in open small bowel resection, in colorectal from 0.3% in minimally invasive sigmoid colectomy to 10.0% in emergency open total proctocolectomy, and in upper gastrointestinal/hepatopancreatobiliary from 0.2% in laparoscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer. Conclusions: VTE thromboprophylaxis provides net benefit through VTE reduction with a small increase in bleeding in some procedures (eg, open colectomy and open pancreaticoduodenectomy), whereas the opposite is true in others (eg, laparoscopic cholecystectomy and elective groin hernia repairs). In many procedures, thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.
KW - bariatric surgery
KW - baseline risk
KW - bleeding
KW - colorectal surgery
KW - general surgery
KW - hepatopancreatobiliary surgery
KW - risk of bias
KW - surgery
KW - thromboprophylaxis
KW - venous thromboembolism
KW - 3126 Surgery, anesthesiology, intensive care, radiology
U2 - 10.1097/SLA.0000000000006059
DO - 10.1097/SLA.0000000000006059
M3 - Review Article
C2 - 37551583
AN - SCOPUS:85179278449
SN - 0003-4932
VL - 279
SP - 213
EP - 225
JO - Annals of Surgery
JF - Annals of Surgery
IS - 2
ER -